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Undetected medical conditions can be misdiagnosed as Conversion Disorder/Functional Neurological 
Disorder(CD/FND). Although misdiagnosis is considered a rare occurrence since the introduction of 
improved diagnostic imaging procedures,(1-3) there is no  recent estimate of this. We therefore 
conducted a study to explore how often a medical condition was misdiagnosed as CD/FND in a sample 
of consecutive outpatients referred for treatment to the Clinical Centre of Excellence for Body Mind 
and Health (CLGG); a tertiary mental health centre for Somatic Symptom Disorders and Related 
Disorders (SSRD). Patients had been diagnosed with CD/FND elsewhere. We systematically explored 
the type and duration of CD/FND, psychiatric and somatic comorbidity, early childhood trauma, 
childhood sexual abuse, stressful life events, use of medication, family history of CD/FND and 
demographic factors in all patients. We evaluated which of these predictors were associated with 
misdiagnosis.  
2. Methods
The current study used a cross-sectional observational design with inclusion between February 1st
2010 and December 31st 2017. The research protocol was approved by the IRB of GGz Breburg (2017–
03/ 2019-01). 
2.1 Description of setting and sampling technique
CLGG provides expert diagnosis, treatment and second opinions for the 5% of the most complex 
patients with SSRD in the Netherlands. It was awarded for its rigorous standards in research, diagnostic 
evaluations and treatment provision in 2014 and 2019. CLGG is nationally one of the last resorts for 
treatment resistant cases, and patients at intake on average received treatment for 5 years 
elsewhere.(4) 
The standard intake procedure at the CLGG includes assessment of psychological symptoms, adverse 
childhood events and stressful life events by questionnaires; semi structured psychiatric 
evaluation(PSE) and psycho-diagnostic assessment complemented by MINI interview;(5) assessment 
of somatic symptoms by a questionnaire measuring physical symptoms, medical history and a physical 
examination including a neurological component. The patient’s existing somatic history and diagnostic 
assessments that led to the diagnosis of CD/FND are then reviewed, compared with the findings at 
intake, and discussed in a multidisciplinary team meeting which includes medical doctors, 
psychiatrists, (neuro)psychologists, and a nurse specialised in trauma treatment. After this 
multidisciplinary review, any diagnostic considerations are revisited with the referring clinician and 
DSM-IV(6) and DSM-5(7) classification as CD/FND or as misdiagnosis is established. 
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2.2 Statistical analysis
Chi-squared analyses and independent samples t-tests explored differences in demographic, clinical 
or other predictive characteristics between confirmed CD/FND cases versus misdiagnosed cases. 
3. Results
Based upon this systematic re-evaluation of cases, it became apparent that nine(12%) patients had an 
underlying medical condition explaining their initial and current somatic symptoms. The diagnosis and 
medical disciplines involved in the original CD/FND diagnosis are listed in Table 1. - Insert Table 1 -  
No significant differences were observed in the presence of predictors between the confirmed 
CD/FND cases and the misdiagnosed cases, as shown in Table 2. This would suggest that, although 
comorbidity, trauma and current stressors are often present in CD/FND, exploring such patient factors 
cannot contribute to establishing the diagnosis CD/FND. – Insert Table 2. – 
4. Discussion
Several serious chronic medical conditions came to light, which had remained hidden and had been 
left untreated for long periods of time. We consider this finding of high clinical relevance, as, given 
existing neurological literature, we would expect a much smaller percentage of misdiagnosed cases.(8) 
Furthermore, primary care studies found that repeated diagnostic assessments conducted after well-
performed initial diagnostic procedures, identified no or only 0.5% underlying medical conditions in 
patients with medically unexplained symptoms(MUS)(9). Based on that research, Dutch guidelines 
recommend to abstain from repeat diagnostic procedures in MUS(10, 11) and the multidisciplinary 
treatment guideline for CD/FND omits the possibility of misdiagnosis completely.(12) However, while 
such recommendations may apply to a broad range of MUS in the primary care setting, in addition  to 
CD/FND in neurology settings, they may not necessarily apply to cases of CD/FND receiving years of 
unsuccessful treatment after initial diagnostic assessment. 
The misclassification of unrecognised underlying somatic conditions as CD/FND may occur more often 
in severe and chronic cases, such as underlying neurological conditions with slow, insidious onset, 
including progressive supranuclear palsy,(13) MSA, and hypertensive leukoencephalopathy. Rare 
conditions such as epileptic transient global amnesia may go unrecognized. Conditions such as Morbus 
Hashimoto have a higher chance to be missed due to their variable prevalence in different 
populations, as well as an often undetected (depending on diagnostic tests used)  preclinical stage.(14) 
Diseases which present in more severe forms than a priori expected can go undetected in conditions 
such as Ehlers Danlos Syndrome or endometriosis. This may especially occur in patients who have 
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difficulty expressing themselves,(15) for example because of language, cultural background, education 
level, age, or feelings of shame. Treatment settings may also be a relevant factor as they may lack 
appropriate expertise or infrastructure to explore these conditions as possible options. For example, 
specialty mental health settings often lack integrated somatic services, especially if they are based 
outside the general hospital setting. Whilst avoiding unnecessary tests and iatrogenic harm remains 
of paramount importance,(16) clinicians should be aware that a substantial percentage of chronic 
CD/FND patients may have an underlying disease. 
5. Limitations
Although the study size is larger than in most other studies, and similar to the 1998 landmark study 
on CD,(1) the sample size can be considered a limitation. 
6. Conclusions
Our findings show that misdiagnosis of an underlying medical condition as CD/FND still occurs in 
chronic cases within the specialist mental health setting. Large scale interdisciplinary research studies 
with collaborating psychiatrists and neurologists are required to confirm these findings and to 
contribute to the re-evaluation of guidelines for assessment of CD/FND. Also, these findings warrant 
the serious consideration of diagnostic re-evaluations in chronic cases. There is a clear call for 
structurally embedding somatic re-examination and re-evaluation in specialist mental health settings, 
by consultation liaison and integrated care models which involve psychiatrists, referring neurologists 
and primary care physicians. Such a provision, that has shown to be beneficial at case level,(13) is 
unfortunately not currently widely available. Policymakers should support the development of such 
sustainable somatic evaluation facilities and services. 
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Table 1. Characteristics of misdiagnosed cases (N=9)












ACE Somatic diagnosis Confirmed by
63 Female 48 months Psychiatrist Neurologist Falling Yes, childhood 
sexual abuse
Progressive Supranuclear Palsy Neurologist* after consultation by 
multidisciplinary team CLGG; MRI







Weakness No Ehlers Danlos Syndrome Multidisciplinary team CLGG in 
consultation with referring clinicians
68 Female 24 months Psychiatrist Internal medicine Tremor No M. Parkinson, later Multiple 
System Atrophy (MSA)
Neurologist, and second opinion 
neurologist
39 Female 60 months Psychiatrist Neurologist Pressure head, 
fatigue
No, but sexual 
abuse at 19 
years
Myopia Multidisciplinary team CLGG in 
consultation with referring clinicians






No Epileptic Transient Global Amnesia Neurologist, Epilepsy clinic








No Treatment resistant hypertension 
and  leukoencephalopathy
Multidisciplinary team CLGG in 
consultation with referring clinicians







No M. Hashimoto, treatment resistant Multidisciplinary team CLGG in 
consultation with referring clinicians









Pseudoradicular syndrome Multidisciplinary team CLGG in 
consultation with referring clinicians
21 Female 108 months Psychiatrist Neurologist Pain, falling No Endometriosis with vasovagal 
collapses
Multidisciplinary team CLGG in 
consultation with gynecologist 
 Case described in (34)






n % n %
Sex
Male 13 20.3 2 22.2
Female 51 79.5 7 77.8
0.018 .894
Age M= 43.14 SD= 11.58 M= 41.33 SD= 16.74 t = 0.414 .680
Relationship status
Single 21 32.8 3 33.3
Cohabiting 14 21.9 0 0
Married 24 37.5 6 66.7
Long-distance 5 7.8 0 0
4.306 .230
Family status
Single no children 20 31.3 3 33.3
Single with children 7 10.9 0 0
Partner no children 10 15.6 2 22.2
Partner with children 27 42.2 4 44.4
1.214 .750
Social Network
Good 27 42.2 4 44.4
Mediocre 31 48.4 5 55.6
Bad 5 7.8 0 0
0.782 .676
Education
Very low 8 12.5 1 11.1
Low 20 31.3 3 33.3
Middle 23 35.9 4 44.4
High 9 14.1 1 11.1
Very High 1 1.6 0 0
0.338 .987
Work status
Working 13 20.3 2 22.2
Sickness Benefits 15 23.4 2 22.2
Unemployment benefits 4 6.3 0 0
Social assistance benefit 7 10.9 0 0
Disabled 18 28.1 2 22.2
Retired 2 3.1 1 11.1
3.089 .686
Family member with CD/FND 0 0 0 0 - -
Family member with other 
psychiatric disorder
24 37.5 3 33.3 0.503 .478
Type of Conversion disorder
With sensoric symptoms 5 7.8 0 0 3.058 .548
With motor symptoms 25 39.1 5 55.6
With non-epileptic seizures 9 14.1 1 11.1
With mixed symptoms 17 26.6 1 11.1
Other 6 9.4 0 0
Time between symptom onset 
to start of treatment
<3 months 5 7.8 1 11.1 1.143 .767
3 – 6 months 6 9.4 0 0
6 – 12 months 10 15.6 2 22.2
>12 months 42 65.6 6 66.7
Onset
Acute 27 42.2 3 33.3 0.256 .613
Gradually 37 57.8 6 66.7
Time from symptom onset to 




SD= 70.49 M= 46.22 SD= 33.05 t = 0.621 .536
Comorbid disorders
Personality disorder 26 40.6 3 33.3 5.416 .067
Anxiety disorder 31 48.4 3 33.3 0.723 .395
Depressive disorder 27 42.2 3 33.3 0.256 .613
Psychotic disorder 2 3.1 0 0 0.289 .591
Developmental disorder 11 17.2 0 0 1.821 .177
Addiction 3 4.7 1 11.1 0.629 .428
Thyroid disorder 7 10.9 2 22.2 0.930 .335
Adrenal disorder 0 0 0 0 - -
Other somatic disorder 17 26.6 1 11.1 1.014 .314
Stroke 7 10.9 0 0 1.089 .297
Epilepsy 2 3.1 0 0 0.289 .591
Other neuro condition 6 9.4 1 11.1 0.027 .868
Other somatic condition 40 62.5 8 88.9 2.440 .118
Use of Medication
Antidepressants 29 45.3 4 44.4 0.002 .961
Benzodiazepines 17 26.6 1 11.1 1.014 .314
Anti-psychotics 5 7.8 1 11.1 0.114 .736
Pain medication 24 37.5 1 11.1 2.440 .118
Opiates 12 18.8 2 22.2 0.061 .804
Childhood trauma 45 70.3 5 55.6 0.935 .334
Recent life event 41 64.1 6 66.7 0.001 .975
Sexual abuse in childhood 17 26.6 2 22.2 0.077 .781
Death of a loved one 3 4.7 1 11.1 0.629 .428
*p<0.05; **p<0.01 X2=chi squared, M= mean, SD= standard deviation.
